Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

Novo Nordisk said on Monday it would halt its collaboration with Hims & Hers Health over the sale of weight loss drugs.

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped ...

Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful ...

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

The shipments have propelled Ireland, a country of only 5.4 million people, to the second-largest goods-trade imbalance with ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its ...

Plus, we take an in-depth look at another possible weight loss solution for patients who’ve tried other methods and failed.

GLP-1 therapies primarily use single-use injectable pens, contributing to medical waste challenges. The pharmaceutical ...